Literature DB >> 8412983

Interactions between tumoral MCF7 cells and fibroblasts on matrigel and purified laminin.

A Noël1, B Nusgens, C H Lapiere, J M Foidart.   

Abstract

A reconstituted basement membrane (matrigel) and/or fibroblasts promote the growth of human breast tumors in athymic nude mice. We have investigated in vitro the effect of matrigel or purified glycoproteins (laminin and fibronectin) on tumoral MCF7 cells-fibroblasts interactions. In coculture on matrigel, MCF7 cells organized into clusters attached on top of fibroblasts aggregates. During the process resulting in tumor cells-fibroblasts aggregation, fibroblasts actively migrated while MCF7 cells were passively transported. Using purified proteins, specific antibodies and synthetic peptides, we show that cell aggregation induced by immobilized and soluble laminin is antagonized by exogenous fibronectin or fibronectin synthesized by fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412983

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  3 in total

1.  Effect of MRC-5 fibroblast conditioned medium on breast cancer cell motility and invasion in vitro.

Authors:  N Heylen; R Baurain; C Remacle; A Trouet
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

2.  Stromal matrix metalloproteinase 2 regulates collagen expression and promotes the outgrowth of experimental metastases.

Authors:  Andreia L Bates; Michael W Pickup; Miranda A Hallett; E Ashley Dozier; Stacy Thomas; Barbara Fingleton
Journal:  J Pathol       Date:  2015-01-05       Impact factor: 7.996

3.  Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System.

Authors:  Trivia Frazier; Christopher Williams; Michael Henderson; Tamika Duplessis; Emma Rogers; Xiying Wu; Katie Hamel; Elizabeth C Martin; Omair Mohiuddin; Shahensha Shaik; Ram Devireddy; Brian G Rowan; Daniel J Hayes; Jeffrey M Gimble
Journal:  Tissue Eng Part A       Date:  2021-03-10       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.